Specialized regenerative therapy designed to reduce neuroinflammation, support nerve healing, and address both the structural causes of nerve compression and the nerve's inflammatory response.
Neuropathic pain arising from spine conditions involves two distinct mechanisms: structural nerve compression and neural inflammation. Structural compression from a disc bulge or bony stenosis creates mechanical irritation; neural inflammation amplifies the pain signal, creating persistent burning, tingling, and numbness that continues even when the mechanical compression is modest. Many patients with mild structural stenosis experience severe neuropathic symptoms because the inflammatory component is driving pain out of proportion to the degree of narrowing.
Conventional treatments address one or the other, but rarely both. Anti-inflammatory medications suppress inflammation temporarily but do not support nerve healing and often mask progressive neural damage. Nerve blocks and epidural steroid injections provide temporary relief by suppressing inflammation remotely from the nerve root. Physical therapy improves stability but cannot heal an inflamed nerve. Surgery removes the structural compression but does not address the neural inflammation that has already occurred.
Regenerative medicine approaches neuropathic pain differently, targeting both the structural cause and the neural consequence. By delivering neurotrophic factors and cells with anti-inflammatory signaling directly to the perineural environment, the goal is to support nerve healing and shift the neural microenvironment from inflammation toward repair.
Regenerative medicine for neuropathic spine pain focuses on creating a biological environment that supports nerve healing. The treatments we use are designed to deliver neurotrophic factors - brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and glial cell-derived neurotrophic factor (GDNF) - that may support nerve survival, reduce neuroinflammation, and promote axonal repair. When delivered to the epidural space or perineural environment, these biologics create a milieu that favors nerve healing rather than ongoing inflammation.
Regenerative cellular therapy provides additional immunomodulatory benefit. Mesenchymal cells have been observed to shift macrophage phenotype from M1 (pro-inflammatory) to M2 (pro-healing), which may reduce the chronic inflammatory state around damaged nerve roots. This immunomodulatory effect is thought to address one of the key drivers of persistent neuropathic pain.
Emerging research on exosome-mediated neuroprotection suggests that exosomes derived from mesenchymal stem cells carry microRNA and bioactive molecules that can modulate neural inflammation at the molecular level. This is an area of active investigation with promising early results.
Critically, I also address any residual structural contributors. If a patient has neuropathic pain from chronic nerve root compression, treating the nerve alone without addressing the disc or stenosis causing the compression is incomplete. The regenerative approach treats both the structural cause and the neural consequence.
Evaluation includes a detailed neurological examination, imaging review, and electrodiagnostic studies when indicated to characterize the neuropathic component. Treatment is delivered under image guidance to ensure precise delivery to the perineural environment.
Nerve tissue heals on its own timeline. We track neurological symptoms carefully, including pain quality, sensory changes, and functional capacity.
Neuropathic pain can be effectively managed with regenerative medicine when both the structural cause and the neural inflammation are addressed. Let's evaluate your specific condition.